Abstract:Protein-polymer conjugates are important therapeutics for various diseases.There are currently two major challenges in this field:one is the search of new biodegradable polymers beyond traditional PEGylation,and the other is to develop highly efficient and site-specific conjugation strategy.Poly(α-amino acid)s (PαAAs) are biodegradable and biocompatible polymers with tunable properties and numerous functions,making them promising candidates for protein modification.In this review,we summarize our recent progresses in protein-PαAAs conjugates.Specifically,we discuss our developments in:(1) Recent developments in the controlled ring-opening polymerization (ROP) of α-amino acid N-carboxyanhydrides (NCAs),including amine-based initiators,organometallic initiators,organosilicon amines initiators and sulfide-based initiators.For instance,trimethylsilyl phenylsulfide (PhSTMS) is a novel initiator for controlled ROP of NCAs.It exhibits higher nucleophilicity than conventional amine-based initiator,and thus affords considerably higher chain initiation rate to ensure a more controlled polymerization.Moreover,this initiator is well-tolerated to various functional groups.(2) In situ functionalization of PαAAs for site-specific protein conjugation,and construction of various topological structures.Using PhSTMS initiator,it in situ generates a reactive phenyl thioester group at one end of the PαAAs,which can be used for protein N-terminus conjugation via native chemical ligation (NCL);moreover,ROP of glycine NCA yields oligoglycine at the other end of PαAAs,which can be used for C-terminus protein conjugation via sortase-A mediated ligation (SML).More interestingly,combinatory use of the two methods can construct various topological protein-PαAA conjugates including the head-to-tail circular conjugates.(3) Development of functional PαAAs for potential protein conjugation.Various functional PαAAs have been developed as delivery materials or hydrogels.To further expand the arsenal of PαAAs for potential modulation of protein functions,PαAAs that mimic protein post-translational modifications (PTM) are synthesized;On the other hand,a series of multiple stimuli-responsive PαAAs are also produced.These PαAAs show interesting enzyme,light,and/or thermal responsiveness,which could be potentially harnessed for modulation of protein functions in the future.

Protein PEPylation: A New Paradigm of Protein-Polymer Conjugation.

Zwitterionic Polymer: A New Paradigm for Protein Conjugation beyond PEG

A Novel Zwitterionic Copolymer with A Short Poly(Methyl Acrylic Acid) Block for Improving Both Conjugation and Separation Efficiency of A Protein Without Losing Its Bioactivity

Therapeutic Protein PEPylation: the Helix of Nonfouling Synthetic Polypeptides Minimizes Antidrug Antibody Generation.

Efficient Synthesis and Application of Protein-Poly(alpha-amino Acid) Conjugates

Synthesis of Well-Defined Protein–polymer Conjugates for Biomedicine

Advances in PEGylation of Drug Conjugates

In Situ Growth Of A Stoichiometric Peg-Like Conjugate At A Protein'S N-Terminus With Significantly Improved Pharmacokinetics

Polypegylation of protein using semitelechelic and mid-functional poly(pegma)s synthesized by raft polymerization

Site-selective protein modification with polymers for advanced biomedical applications.

Research progress on the PEGylation of therapeutic proteins and peptides (TPPs)

Clickable,Oxidation-Responsive and Enzyme-Degradable Polypeptide:Synthesis,Characterization and Side Chain Modification

Site-Specific Conjugation of Polymers to Proteins.

The Importance of Poly(ethylene glycol) Alternatives for Overcoming PEG Immunogenicity in Drug Delivery and Bioconjugation

Comparison of Cyclic and Linear PEG Conjugates

Bio-reversible Polypegylation

Recent Advances in Post-polymerization Modifications on Polypeptides: Synthesis and Applications

Polyethylene Glycol–Based Polymer-Drug Conjugates: Novel Design and Synthesis Strategies for Enhanced Therapeutic Efficacy and Targeted Drug Delivery

A simple methodology for the synthesis of heterotelechelic protein-polymer-biomolecule conjugates

A New Approach to Bioconjugates for Proteins and Peptides (“pegylation”) Utilising Living Radical Polymerisation

Polyethylene Glycol‐Like Brush Polymer Conjugate of a Protein Drug Does Not Induce an Antipolymer Immune Response and Has Enhanced Pharmacokinetics than Its Polyethylene Glycol Counterpart